EuroClonality-NGS验证:标准化IG/TR基因重排NGS用于ALL的MRD标记鉴定
EuroClonality-NGS工作组开发并验证了基于扩增子的IG/TR基因重排NGS检测,用于急性淋巴细胞白血病(ALL)的MRD标记鉴定。五家EuroMRD ALL参考实验室对50例诊断期ALL样本进行NGS检测,并与常规Sanger测序比较。NGS鉴定出259条克隆序列(平均5.2条/样本,范围0-14),Sanger测序鉴定出248条(平均5.0条/样本,范围0-14)。
要点
- NGS鉴定出259条克隆序列(平均5.2条/样本,范围0-14),Sanger测序鉴定出248条(平均5.0条/样本,范围0-14)。
- NGS引物相比本地多重PCR覆盖更全面的IG/TR重排类型,并可对双等位基因重排和弱PCR产物进行测序。
- 中心多靶点质控(cPT-QC)在所有实验室间显示高重现性。
核心结论
- 经过验证且重现性良好的EuroClonality-NGS质控检测可用于淋系恶性肿瘤中基于NGS的标准化IG/TR标记鉴定。
研究设计与样本
- EuroClonality-NGS工作组开发了包括生物信息学在内的IG/TR检测,并在急性淋巴细胞白血病(ALL)中验证用于MRD标记鉴定。
- 五家EuroMRD ALL参考实验室对50例诊断期ALL样本进行IG/TR NGS检测,并与常规IG/TR Sanger测序结果比较。
主要发现
- NGS鉴定出259条克隆序列(平均5.2条/样本,范围0-14),Sanger测序鉴定出248条(平均5.0条/样本,范围0-14)。
- NGS引物相比本地多重PCR覆盖更全面的IG/TR重排类型,并可对双等位基因重排和弱PCR产物进行测序。
- 中心多靶点质控(cPT-QC)在所有实验室间显示高重现性。
关键数值与推荐
- 采用中心多靶点质控(cPT-QC)监测引物性能。
- 每份样本加入中心管内质控(cIT-QC)作为文库特异性质控和校准品。
临床怎么用
- 这些经过验证且重现性良好的EuroClonality-NGS质控检测可用于淋系恶性肿瘤中基于NGS的标准化IG/TR标记鉴定。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Amplicon-based next-generation sequencing (NGS) of immunoglobulin (IG) and T-cell receptor (TR) gene rearrangements for clonality assessment, marker identification and quantification of minimal residual disease (MRD) in lymphoid neoplasms has been the focus of intense research, development and application. However, standardization and validation in a scientifically controlled multicentre setting is still lacking. Therefore, IG/TR assay development and design, including bioinformatics, was performed within the EuroClonality-NGS working group and validated for MRD marker identification in acute lymphoblastic leukaemia (ALL). Five EuroMRD ALL reference laboratories performed IG/TR NGS in 50 diagnostic ALL samples, and compared results with those generated through routine IG/TR Sanger sequencing. A central polytarget quality control (cPT-QC) was used to monitor primer performance, and a central in-tube quality control (cIT-QC) was spiked into each sample as a library-specific quality control and calibrator. NGS identified 259 (average 5.2/sample, range 0-14) clonal sequences vs. Sanger-sequencing 248 (average 5.0/sample, range 0-14). NGS primers covered possible IG/TR rearrangement types more completely compared with local multiplex PCR sets and enabled sequencing of bi-allelic rearrangements and weak PCR products. The cPT-QC showed high reproducibility across all laboratories. These validated and reproducible quality-controlled EuroClonality-NGS assays can be used for standardized NGS-based identification of IG/TR markers in lymphoid malignancies.
引用
- Brüggemann M, Kotrová M, Knecht H, et al. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study. Leukemia. 2019. PMID: 31243313. doi:10.1038/s41375-019-0496-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。